MicroPort NeuroScientific Corporation (MicroPort Neuro, HKEX: 02172) has released its monthly return for the period ended 30 April 2026, detailing modest share count adjustments driven chiefly by on-market repurchases.
Authorised capital unchanged • The company’s authorised share capital remained at 2.50 billion ordinary shares with a par value of USD 0.00002 each, equivalent to total authorised capital of USD 50,000.
Issued and treasury share movements • Issued shares (excluding treasury) fell by 0.30 million to 575.67 million. • Treasury shares increased by an identical 0.30 million to 9.36 million, leaving total issued shares steady at 585.03 million. • Public float continues to meet the Main Board’s 25 % minimum requirement, as confirmed by the issuer.
Share repurchases • MicroPort Neuro executed three on-market buy-backs on 28-30 April, acquiring a total of 300,000 shares at prices ranging from HK$10.3127 to HK$10.3627 per share. • Aggregate consideration for the month’s repurchases amounted to approximately HK$31.02 million. All repurchased shares are held in treasury.
Share option activity • Under the June 2023 Share Option Scheme, 550,000 new options were granted and 6,000 lapsed, lifting outstanding options to 8.52 million. • 68,800 new shares were issued during the month from option exercises; no cash proceeds were reported. • The scheme permits up to 49.73 million shares to be issued or transferred upon full exercise of outstanding and future grants.
Other capital instruments • The company reported no movements in warrants, convertibles or other share-issue agreements during the period.
The filing, submitted on 6 May 2026 by Company Secretary Yeung Siu Lam, affirms full compliance with Hong Kong Listing Rules and related regulatory requirements.
Comments